SCHEMBL29579018

SCHEMBL29579018

[2H]C([2H])([2H])Oc1c(Cl)cc(C(C)(C)c2ccc(O)cc2)cc1C#N

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ AR P10275 8/20 0.40
▸ ESR1 P03372 5/20 0.40
▸ ESR2 Q92731 5/20 0.40
▸ CYP3A4 P08684 2/20 0.40
▸ HPGD P15428 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ SLC6A2 P23975 1/20 0.40
▸ SLC6A4 P31645 1/20 0.40
▸ HTR6 P50406 1/20 0.40
▸ ESRRG P62508 1/20 0.40
▸ SLC6A3 Q01959 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.40
▸ ALDH1A1 P00352 2/20 0.36
▸ PKM P14618 1/20 0.32
▸ LMNA P02545 1/20 0.30
▸ TYR P14679 1/20 0.30
▸ MAP2K1 Q02750 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31236721 0.93 AR (0.40) ARESR1ESR2CYP3A4HPGD
SCHEMBL24481071 0.91 AR (0.43) ARESR1ESR2CYP3A4HPGD
SCHEMBL29579789 0.91 AR (0.43) ARESR1ESR2CYP3A4HPGD
SCHEMBL29580291 0.84 AR (0.43) ARESR1ESR2CYP3A4HPGD
SCHEMBL24480897 0.84 AR (0.43) ARESR1ESR2CYP3A4HPGD
SCHEMBL29579106 0.81 AR (0.41) ARHPGD
SCHEMBL22468712 0.81 AR (0.49) ARESR1ESR2CYP3A4HPGD
SCHEMBL21854449 0.81 AR (0.54) ARESR1ESR2CYP3A4HPGD
SCHEMBL29447826 0.81 AR (0.54) ARESR1ESR2CYP3A4HPGD
SCHEMBL29448116 0.81 AR (0.49) ARESR1ESR2CYP3A4HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116529248-A Benzene ring derivative, composition and pharmaceutical application thereof 四川海思科制药有限公司 2023-08-01 — — CN disclosed
WO-2022111526-A1 BENZENE RING DERIVATIVE, AND COMPOSITION AND PHARMACEUTICAL USE THEREOF 四川海思科制药有限公司 2022-06-02 — — WO disclosed
Send feedback